by Gemma Escarré,
Mimetis Biomaterials, a bone regeneration company member of CataloniaBio & HealthTech, has initiated an investment round of 2 million euros which will be raised in two phases. It is hoped to secure around 120,000 euros in the seed capital round through crowdfunding and the rest through a Series A round.
The materials manufactured by Mimetis, a company based in the Vallès Technology Park, facilitate the biological processes that regenerate the lost bone of the patient and can be applied in the dental, craniomaxillofacial and orthopaedic fields. Mimetis’ greatest achievement, however, has been 3D-printed custom implants.
The company previously closed two rounds of funding valued at 800,000 euros, according to El Punt Avui.
You will find further information here (presentation, financial statements and diagrams).
Photo: Maria Pau Ginebra, researcher at CREB-UPC and president of Mimetis.